Search Results 531-540 of 17852 for Coagulate

1. Predicting Intestinal Healing in Celiac Disease

   Hello, my name is Joe Murray. I'm a gastroenterologist in the Celiac Disease Program at Mayo Clinic. One of the challenges of following our patients with ...

2. Mayo Clinic

   Clinical Trial at Mayo Clinic Saves Workaholic after Stroke. Share · Tweet . VID-20115891. Home; Brightcove-Stroke Patient Story ...

3. Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma - Mayo Clinic

   ECOG performance status of 0, 1, or 2. Have adequate hematologic (bone marrow [BM] and coagulation factors), renal and hepatic function as defined by criteria ...

4. A Study of Catequentinib, Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma - Mayo Clinic

   ... coagulation parameters exists);; Platelet count ≥ 100,000 cells/mm^3 ... Patients with recent DVT who are treated with therapeutic anti-coagulating ...

5. Deep Vein Thrombosis (DVT) Clinical Trials - Mayo Clinic Research

   Aim 3: Examine biomarkers of coagulation as predictors of acute proximal DVT resolution and PTS. Aim 4: Expand the scope of the Mayo Clinic VTE registry to ...

6. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   Has adequate hematologic (bone marrow [BM] and coagulation factors), renal and hepatic function as defined by criteria below. System Laboratory Value ...

7. Oncology (Medical) - Doctors - Mayo Clinic

   ... coagulation, Bleeding disorder, Benign hematologic condition, Autoimmune hemolytic anemia, Paroxysmal nocturnal hemoglobinuria, Myeloproliferative disorders ...

8. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma - Mayo Clinic

   Adequate coagulation defined as: Prothrombin time (PT) ≤ 1.2 x upper limit of normal. Serum lipids within acceptable range: Serum triglyceride level ≤ 300 ...

9. The Mayo Clinic Congenital Disorders of Glycosylation (CDG) Clinic sees more patients with CDG than any other practice in the U.S. Mayo specialists of the ...

10. Phase 3 Study Of Daraxonrasib (RMC-6236) In Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) - Mayo Clinic

    * Measurable disease per RECIST 1.1. * Adequate organ function (bone marrow, liver, kidney, coagulation) * Documented RAS mutation status, either mutant or ...